09
Jul

Dutch biotech arGEN-X has raised €40 million ($54.5 million) in a Brussels IPO, planning to bankrolling its internal candidates and expand its in-demand antibody technology.

…read more

Source: Antibody expert arGEN-X pulls off a $54.5M IPO

    

0 No comments